Neural Stem Cell Dynamics in Malignant Glioma

Malignant gliomas, including glioblastoma, are characterised by a subpopulation of neural stem cells (NSCs) that drive tumour initiation, progression and therapeutic resistance. These cells display hallmark features of normal NSCs—self-renewal, multipotency and migratory capacity—yet they exploit developmental programmes to sustain malignancy. Within the tumour microenvironment, gradients of oxygen, nutrients and extracellular matrix components create niches that support glioma stem cells (GSCs), a tumour-initiating subset with enhanced DNA-repair mechanisms and resistance to conventional therapies. Dynamic interactions between GSCs and endothelial, immune and stromal cells further reinforce a pro-tumorigenic niche, while plasticity in cell state allows non-stem glioma cells to reacquire stem-like properties under selective pressure. Key signalling pathways—such as Notch, Wnt/β-catenin and SHH—are co-opted to regulate the balance between proliferation and differentiation, and epigenetic regulators fine-tune the transcriptional programmes that govern lineage commitment. Understanding how NSC dynamics intersect with the unique features of the blood-brain-tumour barrier and the immunosuppressive microenvironment offers avenues for targeted therapies that eradicate GSC reservoirs and prevent recurrence.

Research from Nature Portfolio

Recent studies have demonstrated that non-invasive modulation of the blood-brain-tumour barrier can enhance delivery of cytotoxic agents to glioma-associated NSCs. By applying pulsed laser excitation of vascular-targeted nanoparticles, investigators achieved reversible increases in barrier permeability and demonstrated substantial reductions in tumour volume in preclinical glioblastoma models. This approach not only reopens the possibility of repurposing existing chemotherapeutics that previously failed to penetrate the central nervous system but also provides a versatile platform for evaluating new drug candidates against GSC-driven malignancies.

Neural Stem Cell Dynamics in Malignant Glioma publication trend

The graph below shows the total number of articles in neural stem cell dynamics in malignant glioma across all publications each year (not limited to Nature Index journals).

Technical terms

Neural stem cell (NSC): A self-renewing, multipotent cell in the central nervous system that generates neurons and glia during development and adulthood.

Glioma stem cell (GSC): A subpopulation within malignant gliomas that exhibits stem-like features, drives tumour growth and resists therapy.

Blood-brain-tumour barrier (BBTB): A specialised vascular interface in gliomas that restricts drug delivery and contributes to treatment resistance.

OptoBBTB: A technique employing light-activated nanoparticles to transiently modulate the permeability of the BBTB.

In vivo electroporation: A method of delivering genetic material directly into cells within a living organism by applying electrical pulses.

Self-renewal: The process by which stem cells divide to produce at least one daughter cell that retains stem cell properties.

References

1. Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment. Nature Communications (2023).
2. Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023).
3. CREB5 promotes the proliferation and self-renewal ability of glioma stem cells. Cell Death Discovery (2024).
4. The developmental origin of brain tumours: a cellular and molecular framework. Development (2018).